Clearance Summary
Amplatzer Trevisio Intravascular Delivery System received FDA 510(k) clearance under submission number K190581, sponsored by ABBOTT MEDICAL. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2019-04-05.
- Submission: K190581
- Applicant / Sponsor: ABBOTT MEDICAL
- Clearance pathway: Special
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1250
- Decision date: 2019-04-05
Classification & Regulation
This clearance is catalogued under FDA product code DQY and 21 CFR 870.1250, within the Cardiovascular review panel as a Class II device.